Top compounds associated with response to TMEM160


Feature Type Standardized
Nominal ANOVA
mRNA Tamoxifen CTRPv2 pan-cancer AAC -0.083 0.03
mRNA SN-38 GDSC1000 pan-cancer AAC -0.072 0.03
mRNA GDC-0941 GDSC1000 pan-cancer AAC 0.071 0.03
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.075 0.03
mRNA AZD-2281 CTRPv2 pan-cancer AAC -0.074 0.03
mRNA JQ-1:MK-0752 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.071 0.04
mRNA BAY 61-3606 GDSC1000 pan-cancer AAC -0.072 0.04
mRNA Vandetanib CTRPv2 pan-cancer AAC -0.076 0.04
mRNA BRD-A86708339 CTRPv2 pan-cancer AAC 0.11 0.04
mRNA erlotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.078 0.04
Download CSV